-
Advanced Medical Applications, Treatment Solutions, and Biotechnology (.pdf)
, Treatment Solutions,. and Biotechnology. Example 2. End Product: Tomography Control of Magnetic Field Activity. Customer Schematic/Specifications: - Ultra precision attenuator with very high ohmic value. R2 = x R1 (x = 999). ratio: 1:1000. - R1 < 25. R2: 999 x R1. - Ratio definition: R1 to (R1 + R2). R1...
-
Outsourcing Biopharma Water Treatment
for biopharmaceutical customers is validation assistance. A complete validation assistance program may include comprehensive validation documentation and a factory acceptance test (FAT) at the water treatment vendors plant. Factory Acceptance TestingA biotechnology firm on the West Coast asked its water treatment...
-
Evaluation of starch hydrolysing enzymes
, biotechnology, drainage, enzyme, recycled fibre, starch Fibres from recycled boxboard, contains starch that contributes to lower drainage rates and reduced machine speed. The residual starch does not contribute to strength properties and can potentially be degraded by amylases to improve drainage...
-
Catalyst potential of laccase-mediator systems
CATALYST POTENTIAL OF LACCASE-MEDIATOR SYSTEMS AND TRANSITION METAL POLYOXOMETALATES IN OXYGEN BLEACHING OF PULP Sappi Biotechnology Laboratory, Dept. of Microbiology, Biochemistry & Food Science, University of the Free State, PO Box 339, Bloemfontein 9300, South Africa Sappi Management Services...
-
Synergistic interactions of purified xylanases
assistance. 7. LITERATURE CITED 1. Beg, Q., Kapoor, K., Mahajan, M.L. and Hoondal, G.S., "Microbial xylanases and their industrial applications", Applied Microbiology and Biotechnology, 56:326-338 (2001). 2. Wong, K.K.Y., Nelson, S.L. and Saddler, J.N., "Xylanase treatment for the peroxide bleaching...
-
Biogen's LSM Plant; On Line, On Time, On Budget
in gray space. LSM's utilities are typical for a large biotechnology facility. In addition to general utilities, the plant uses process gases, purified water, water-for-injection, clean steam, and HEPA filtration to serve upstream and downstream operations. The site's principal processing suites...
-
America Needs a Biodefense Pharma Sector
for countermeasures. Research and Development Tax Incentives and Manufacturing Grants: The vast majority of research in America is outsourced by brand pharmaceuticals to biotechnology and other smaller companies. Rather than using the brand sector as the middleman, in most instances the federal government...
-
Advancing Your Career in a Changing Industry
compounds developed by biotechnology companies, typically those backed by venture capital investors.Since 2001, more than $71 billion in such transactions have been completed. Today nearly 50% of the drugs marketed by large pharmaceutical companies were developed by companies or institutions other than...
-
Ultrasound: An Environmentally Friendly Tool for the Textile Industry
and Biotechnology in May 2002. By Amy Spillman, Agricultural Research Service Information Staff. This research is part of Quality and Utilization of Agricultural Products, an ARS National Program (#306) described on the World Wide Web at http://www.nps.ars.usda.gov. Val G. Yachmenev and Eugene J. Blanchard...
-
CMO Movers and Shakers: Amylin, Avid, Bilcare, GSK, Lilly, Novartis, Patheon
with Catalyst Biosciences, a biotechnology company. Avid will produce clinical-grade material in support of Catalyst's clinical candidate, CB 813, an improved version of factor VIIa for the treatment of acute bleeding in hemophilia patients. Avid will begin CGMP manufacturing to provide cell bank...